Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma-Reference-Cited by-同舟云学术

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Published:2008-08-28 Issue:9 Volume:359 Page:906-917
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

San Miguel Jesús F.,Schlag Rudolf,Khuageva Nuriet K.,Dimopoulos Meletios A.,Shpilberg Ofer,Kropff Martin,Spicka Ivan,Petrucci Maria T.,Palumbo Antonio,Samoilova Olga S.,Dmoszynska Anna,Abdulkadyrov Kudrat M.,Schots Rik,Jiang Bin,Mateos Maria-Victoria,Anderson Kenneth C.,Esseltine Dixie L.,Liu Kevin,Cakana Andrew,van de Velde Helgi,Richardson Paul G.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0801479

Cited by 1681 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation;Frontiers in Hematology;2024-09-11

2. Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma;Cancers;2024-08-23

3. Comparative efficacy of VMP vs. Rd in newly diagnosed, autologous stem cell transplant-ineligible multiple myeloma patients: a prematurely terminated randomized controlled study, CAREMM-2002 study;Blood Research;2024-07-17

4. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

5. Zelluläre Therapien im Alter: Everything, everywhere, all at once?;InFo Hämatologie + Onkologie;2024-07